Excess renin is attributed to the combination of forward and backward failure in HFrEF.
Backward failure
Forward failure
HFrEF
Renin-angiotensin system
Right ventricular function
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
08 Mar 2024
08 Mar 2024
Historique:
revised:
05
01
2024
received:
21
09
2023
accepted:
06
02
2024
medline:
9
3
2024
pubmed:
9
3
2024
entrez:
9
3
2024
Statut:
aheadofprint
Résumé
Regulation of the renin-angiotensin system (RAS) in heart failure (HF) with reduced ejection fraction (HFrEF) still raises questions, as a large proportion of patients show normal renin levels despite manifest disease. Experimental venous congestion results in reduced renal perfusion pressure and stimulates renin secretion. We hypothesized that excess renin levels are mainly a result of right ventricular failure as a sequalae of left ventricular dysfunction. The study aimed to link right ventricular function (RVF) with renin levels and to investigate further contributors to excess RAS activation. Three hundred thirty-two chronic HFrEF patients undergoing routine ambulatory care were consecutively enrolled in a prospective, registry-based, observational study. Laboratory parameters, including cardiac-specific markers renin, aldosterone, and N-terminal pro-brain natriuretic peptide (NT-proBNP), echocardiographic examination (n = 247), and right heart catheterization (n = 85), were documented. The relationship between renin and its respective parameters was analysed. Renin concentration was not associated with the New York Heart Association class or NT-proBNP. Systolic blood pressure, systemic vascular resistance, serum sodium, aldosterone, and lactate dehydrogenase were associated with increased renin levels (P < 0.035 for all). Renin levels similarly increased with worsening of RVF parameters such as fractional area change, tricuspid annular plane systolic excursion, tissue Doppler imaging, and inferior vena cava diameter (P < 0.011 for all), but not with pulmonary pressure. Excess renin levels were observed when worsening RVF was combined with reduced renal perfusion {625 μIU/mL [interquartile range (IQR): 182-1761] vs. 67 μIU/mL [IQR: 16-231], P < 0.001}, which was associated with worse survival. While unrelated to classical indices of HF severity, circulating renin levels increase with the worsening of RVF, especially in the combined presence of forward and backward failure. This might explain normal renin levels in HFrEF patients but also excess renin levels in poor haemodynamic conditions.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
Ferreira JP, Rossignol P, Zannad F. Renin-angiotensin-aldosterone system and kidney interactions in heart failure. J Renin Angiotensin Aldosterone Syst 2019;20:1470320319889415. doi:10.1177/1470320319889415
Unger T, Li J. The role of the renin-angiotensin-aldosterone system in heart failure. J Renin Angiotensin Aldosterone Syst 2004;5:S7-S10. doi:10.3317/jraas.2004.024
Vergaro G, Emdin M, Iervasi A, Zyw L, Gabutti A, Poletti R, et al. Prognostic value of plasma renin activity in heart failure. Am J Cardiol 2011;108:246-251. doi:10.1016/j.amjcard.2011.03.034
Pavo N, Goliasch G, Wurm R, Novak J, Strunk G, Gyöngyösi M, et al. Low- and high-renin heart failure phenotypes with clinical implications. Clin Chem 2018;64:597-608. doi:10.1373/clinchem.2017.278705
Gheorghiade M, Böhm M, Greene SJ, Fonarow GC, Lewis EF, Zannad F, et al. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: The ASTRONAUT randomized trial. JAMA 2013;309:1125-1135. doi:10.1001/jama.2013.1954
Sparks MA, Crowley SD, Gurley SB, Mirotsou M, Coffman TM. Classical renin-angiotensin system in kidney physiology. Compr Physiol 2014;4:1201-1228. doi:10.1002/cphy.c130040
Pavo N, Yarragudi R, Puttinger H, Arfsten H, Strunk G, Bojic A, et al. Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction. PLoS ONE 2018;13:e0206830. doi:10.1371/journal.pone.0206830
Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009;53:589-596. doi:10.1016/j.jacc.2008.05.068
Doty JM, Saggi BH, Sugerman HJ, Blocher CR, Pin R, Fakhry I, et al. Effect of increased renal venous pressure on renal function. J Trauma 1999;47:1000-1003. doi:10.1097/00005373-199912000-00002
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-3726. doi:10.1093/eurheartj/ehab368
Deng L, Xiong Z, Li H, Lei X, Cheng L. Analytical validation and investigation on reference intervals of aldosterone and renin in Chinese Han population by using fully automated chemiluminescence immunoassays. Clin Biochem 2018;56:89-94. doi:10.1016/j.clinbiochem.2018.04.016
Dorrian CA, Toole BJ, Alvarez-Madrazo S, Kelly A, Connell JMC, Wallace AM. A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin. Ann Clin Biochem 2010;47:195-199. doi:10.1258/acb.2010.009230
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:1-39.e14. doi:10.1016/j.echo.2014.10.003
Schneider M, Binder T. Echocardiographic evaluation of the right heart. Wien Klin Wochenschr 2018;130:413-420. doi:10.1007/s00508-018-1330-3
Peti-Peterdi J, Harris RC. Macula densa sensing and signaling mechanisms of renin release. J Am Soc Nephrol 2010;21:1093-1096. doi:10.1681/asn.2009070759
Tsutamoto T, Sakai H, Tanaka T, Fujii M, Yamamoto T, Wada A, et al. Comparison of active renin concentration and plasma renin activity as a prognostic predictor in patients with heart failure. Circ J 2007;71:915-921. doi:10.1253/circj.71.915
Masson S, Solomon S, Angelici L, Latini R, Anand IS, Prescott M, et al. Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: Data from the Valsartan Heart Failure Trial (Val-HeFT). J Card Fail 2010;16:964-970. doi:10.1016/j.cardfail.2010.06.417
La Gerche A, Claessen G. Right ventricular function: The barometer of all that lies ahead. JACC Cardiovasc Imaging 2019;12:2386-2388. doi:10.1016/j.jcmg.2018.12.018
Campbell SE, Janicki JS, Weber KT. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol 1995;27:1545-1560. doi:10.1016/s0022-2828(95)90359-3
Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, et al. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 1998;273:4883-4891. doi:10.1074/jbc.273.9.4883
Robert V, Heymes C, Silvestre JS, et al. Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: Role in aldosterone-salt-induced fibrosis. Hypertension 1999;33:981-986. doi:10.1161/01.hyp.33.4.981
Gong SZ, Liu PQ, Lu W, et al. Effect of aldosterone on the secretion of endothelin by ventricular fibroblasts. Sheng Li Xue Bao 2001;53:23-26.
Gregori M, Tocci G, Giammarioli B, Befani A, Ciavarella GM, Ferrucci A, et al. Abnormal regulation of renin angiotensin aldosterone system is associated with right ventricular dysfunction in hypertension. Can J Cardiol 2014;30:188-194. doi:10.1016/j.cjca.2013.11.009
Michelfelder EC, Vermilion RP, Ludomirsky A, Beekman RH, Lloyd TR. Comparison of simultaneous Doppler- and catheter-derived right ventricular dP/dt in hypoplastic left heart syndrome. Am J Cardiol 1996;77:212-214. doi:10.1016/s0002-9149(96)90604-9
Lindqvist P, Waldenström A, Wikström G, Kazzam E. The use of isovolumic contraction velocity to determine right ventricular state of contractility and filling pressures: A pulsed Doppler tissue imaging study. Eur J Echocardiogr 2005;6:264-270. doi:10.1016/j.euje.2004.11.002
Carr DH, Jennings DB, Thrasher TN, Keil LC, Ramsay DJ. Role of right heart receptors in the control of renin, vasopressin, and cortisol secretion in dogs. Am J Physiol 1992;263:R1071-R1077. doi:10.1152/ajpregu.1992.263.5.R1071
Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors AA. The role of the kidney in heart failure. Eur Heart J 2012;33:2135-2142. doi:10.1093/eurheartj/ehs205
Damman K, Navis G, Smilde TD, et al. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 2007;9:872-878. doi:10.1016/j.ejheart.2007.05.010
Ljungman S, Laragh JH, Cody RJ. Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 1990;39:10-21; discussion 22-14. doi:10.2165/00003495-199000394-00004
Goldsmith SR, Sobotka PA, Bart BA. The sympathorenal axis in hypertension and heart failure. J Card Fail 2010;16:369-373. doi:10.1016/j.cardfail.2009.12.022
Damman K, Testani JM. The kidney in heart failure: An update. Eur Heart J 2015;36:1437-1444. doi:10.1093/eurheartj/ehv010
Mullens W, Abrahams Z, Skouri HN, Francis GS, Taylor DO, Starling RC, et al. Elevated intra-abdominal pressure in acute decompensated heart failure: A potential contributor to worsening renal function? J Am Coll Cardiol 2008;51:300-306. doi:10.1016/j.jacc.2007.09.043
Guglin M, Rivero A, Matar F, Garcia M. Renal dysfunction in heart failure is due to congestion but not low output. Clin Cardiol 2011;34:113-116. doi:10.1002/clc.20831
Kastner PR, Hall JE, Guyton AC. Renal hemodynamic responses to increased renal venous pressure: Role of angiotensin II. Am J Physiol 1982;243:F260-F264. doi:10.1152/ajprenal.1982.243.3.F260
Argulian E, McPherson C, Kukin M. Organ-specific responses to circulatory disturbances in heart failure: New insights. Congest Heart Fail 2012;18:127-131. doi:10.1111/j.1751-7133.2011.00253.x